CytomX Therapeutics Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

0.76

0.02 (2.11%)

At close: May 01, 2025, 3:59 PM

0.77

1.89%

Pre-market: May 02, 2025, 09:14 AM EDT

CytomX Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	138.1M	101.21M	53.16M	69.57M	100.36M	57.49M	59.5M	71.62M	15.04M
Cost of Revenue	1.77M	n/a	5.86M	5.84M	n/a	n/a	n/a	n/a	n/a
Gross Profit	136.34M	101.21M	47.31M	63.73M	100.36M	57.49M	59.5M	71.62M	15.04M
Operating Income	25M	-6.48M	-101.33M	-83.78M	-48.6M	-110.89M	-77.87M	-46.26M	-59.59M
Interest Income	7.14M	9.84M	1.68M	255K	1.84M	8.37M	7.64M	2.67M	2.42M
Pretax Income	32.09M	3.32M	-99.32M	-83.61M	-46.8M	-102.67M	-70.3M	-43.61M	-58.92M
Net Income	31.87M	-569K	-97.3M	-80.65M	-32.88M	-102.24M	-84.6M	-43.1M	-58.9M
Selling & General & Admin	29.73M	30.02M	42.85M	39.16M	36.03M	36.77M	33.51M	25.61M	19.87M
Research & Development	83.38M	77.68M	111.65M	114.19M	112.94M	131.62M	103.87M	92.28M	54.76M
Other Expenses	n/a	n/a	340K	-83K	-27K	-135K	-68K	-27K	-69K
Operating Expenses	113.11M	107.7M	154.5M	153.35M	148.97M	168.38M	137.38M	117.88M	74.63M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.69M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	113.11M	107.7M	154.5M	153.35M	148.97M	168.38M	137.38M	117.88M	74.63M
Income Tax Expense	224K	3.89M	-2.02M	-2.96M	-13.91M	-427K	14.3M	-513K	-19K
Shares Outstanding (Basic)	84.44M	73.81M	65.74M	64.15M	46.15M	45.34M	41.66M	37.17M	36.23M
Shares Outstanding (Diluted)	84.75M	73.81M	65.74M	64.15M	46.15M	45.34M	41.66M	37.17M	36.23M
EPS (Basic)	0.38	-0.01	-1.48	-1.26	-0.71	-2.26	-2.03	-1.16	-1.63
EPS (Diluted)	0.38	-0.01	-1.48	-1.26	-0.71	-2.26	-2.03	-1.16	-1.63
EBITDA	25M	-4.31M	-98.89M	-113.34M	-77.97M	-138.88M	-75.99M	-41.97M	-57.85M
EBIT	25M	-6.48M	-101.33M	-116.04M	-80.54M	-102.67M	-77.87M	-43.61M	-57.23M
Depreciation & Amortization	n/a	2.17M	5.86M	5.84M	5.46M	2.6M	1.88M	1.65M	1.73M